论文部分内容阅读
目的探讨依达拉奉联合疏血通治疗急性脑梗死患者的临床效果。方法选取2014年6月至2015年6月河南省焦作煤业集团中央医院收治的200例急性脑梗死患者作为研究对象,采用随机数字表法将其分为对照组和研究组,各100例。对照组患者给予疏血通,研究组患者在对照组基础上采用依达拉奉进行治疗,比较两组患者治疗前后日常生活能力、神经功能缺损程度、临床疗效及不良反应发生情况。结果治疗后,研究组患者的欧洲卒中量表(ESS)、日常生活能力量表(ADL)评分均明显高于对照组,而神经功能缺损程度评分量表(CSS)评分明显低于对照组,差异均有统计学意义(均P<0.05);研究组患者治疗的总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论依达拉奉联合疏血通治疗急性脑梗死临床效果明显,可有效改善患者神经功能缺损程度,提高日常生活能力。
Objective To investigate the clinical effect of edaravone combined with Shuxuetong in the treatment of patients with acute cerebral infarction. Methods A total of 200 acute cerebral infarction patients admitted from Central Hospital of Jiaozuo Coal Mining Group in Henan Province from June 2014 to June 2015 were selected as study subjects and divided into control group and study group with 100 cases in each group by random number table. Patients in the control group were treated with Shuxuetong. The patients in the study group were treated with edaravone on the basis of the control group. The daily living ability, the degree of neurological deficits, clinical efficacy and adverse reactions before and after treatment were compared between the two groups. Results After treatment, the ESS and ADL scores of the study group were significantly higher than those of the control group, while the score of neurological deficit score was significantly lower than that of the control group, (All P <0.05). The total effective rate of treatment in study group was significantly higher than that in control group, with significant difference (P <0.05). Conclusion Edaravone combined with Shuxuetong has obvious clinical effect in treating acute cerebral infarction, which can effectively improve the degree of neurological deficit and improve the ability of daily living.